Evaluation of the efficacy and safety of endoscopic band ligation in the treatment of bleeding from mild to moderate gastric varices type 1

Table 1 Comparison of the baseline data between the two groups of patients

	EBL group (n = 50)	TAI group (n = 50)	χ2/t/U	P value
Sex, n (%)
Male	45 (88.2)	43 (84.3)	/	0.4871
Female	6 (11.8)	8 (15.7)
Age (yr, mean ± SD)	52.78 ± 8.50	52.92 ± 9.65	0.076	0.9392
Causes of disease, n (%)			3.744	0.6301
Hepatitis B liver cirrhosis	28 (54.9)	26 (51.0)
alcoholic cirrhosis	11 (21.6)	13 (25.5)
Hepatitis C cirrhosis	6 (11.7)	2 (3.9)
Autoimmune liver cirrhosis	1 (2.0)	3 (5.9)
Hepatitis B liver cirrhosis with alcoholic cirrhosis	4 (7.8)	6 (11.7)
Other cause	1 (2.0)	1 (2.0)
Child-Pugh classification, n (%)			-0.377	0.7063
A	11 (21.6)	10 (19.6)
B	37 (72.6)	37 (72.6)
C	3 (5.8)	4 (7.8)
Diameter of gastric varices (mm)	15.0	14.0	-1.459	0.1353
Diameter of the portal vein (mm)	8.0	9.0	-1.280	0.2003

¹Fisher’s test.

²t test.

³Mann-Whitney U test.

The values are expressed as the mean ± SD or median. EBL: Endoscopic band ligation; TAI: Tissue adhesive injection.